Gene · 54578
Papers1,780
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,780
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Modeling the protein binding non-linearity in population pharmacokinetic model of valproic acid in children with epilepsy: a systematic evaluation study. | Front Pharmacol | 2023 | 37869748 | PubTator, text mining | PubMed |
| Familial Risk and Interaction With Smoking and Alcohol Consumption in Bladder Cancer: A Population-Based Cohort Study. | World J Oncol | 2023 | 37869241 | PubTator, text mining | PubMed |
| Genetic Polymorphisms of UDP-Glucuronosyltransferases and Susceptibility to Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis. | J Trop Med | 2023 | 37868740 | PubTator, text mining | PubMed |
| Novel In Vitro Models for Cell Differentiation and Drug Transport Studies of the Human Intestine. | Cells | 2023 | 37830585 | PubTator, text mining | PubMed |
| Dysregulated meta-organismal metabolism of aromatic amino acids in alcohol-associated liver disease. | Hepatol Commun | 2023 | 37820283 | PubTator, text mining | PubMed |
| Advances in drug resistance of triple negative breast cancer caused by pregnane X receptor. | World J Clin Oncol | 2023 | 37771631 | PubTator, text mining | PubMed |
| Mutual Modulation of the Activities of Human CYP2D6 and Four UGTs during the Metabolism of Propranolol. | Curr Issues Mol Biol | 2023 | 37754235 | PubTator, text mining | PubMed |
| Genomic biomarkers: Unveiling the potential for precise cancer therapy response. | Indian J Pharmacol | 2023 | 37737072 | PubTator, text mining | PubMed |
| Physiologically based mechanistic insight into differential risk of valproate hepatotoxicity between children and adults: A focus on ontogeny impact. | CPT Pharmacometrics Syst Pharmacol | 2023 | 37735924 | PubTator, text mining | PubMed |
| Bioinformatical analysis of the key differentially expressed genes for screening potential biomarkers in Wilms tumor. | Sci Rep | 2023 | 37717078 | PubTator, text mining | PubMed |
| Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease. | Front Endocrinol (Lausanne) | 2023 | 37701897 | PubTator, text mining | PubMed |
| Lung cancer associated with combustion particles and fine particulate matter (PM2.5) - The roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR). | Biochem Pharmacol | 2023 | 37696458 | PubTator, text mining | PubMed |
| Establishment of UGT1A1-knockout human iPS-derived hepatic organoids for UGT1A1-specific kinetics and toxicity evaluation. | Mol Ther Methods Clin Dev | 2023 | 37663646 | PubTator, text mining | PubMed |
| Pharmacological diversity amongst approved and emerging antiseizure medications for the treatment of developmental and epileptic encephalopathies. | Ther Adv Neurol Disord | 2023 | 37655228 | PubTator, text mining | PubMed |
| Cenobamate (YKP3089) and Drug-Resistant Epilepsy: A Review of the Literature. | Medicina (Kaunas) | 2023 | 37629678 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Surrogates for Drug Metabolism and Clearance: Promise vs. Reality. | Life (Basel) | 2023 | 37629602 | PubTator, text mining | PubMed |
| Pharmacokinetic and Pharmacodynamic Drug-Drug Interactions: Research Methods and Applications. | Metabolites | 2023 | 37623842 | PubTator, text mining | PubMed |
| Ritlecitinib: First Approval. | Drugs | 2023 | 37556041 | PubTator, text mining | PubMed |
| Aberrations in ion channels interacting with lipid metabolism and epithelial-mesenchymal transition in esophageal squamous cell carcinoma. | Front Mol Biosci | 2023 | 37529379 | PubTator, text mining | PubMed |
| Association of Acetaminophen With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Pharmacologic Considerations and Treatment Options. | Cureus | 2023 | 37519510 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54578/papers?page=5